Cholesterol absorption and synthesis markers in individuals with and without a CHD event during pravastatin therapy: insights from the PROSPER trial

Cholesterol homeostasis, defined as the balance between absorption and synthesis, influences circulating cholesterol concentrations and subsequent coronary heart disease (CHD) risk. Statin therapy targets the rate-limiting enzyme in cholesterol biosynthesis and is efficacious in lowering CHD events...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Matthan, Nirupa R., Resteghini, Nancy, Robertson, Michele, Ford, Ian, Shepherd, James, Packard, Chris, Buckley, Brendan M., Jukema, J. Wouter, Lichtenstein, Alice H., Schaefer, Ernst J.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: The American Society for Biochemistry and Molecular Biology 2010
Θέματα:
Patient-Oriented and Epidemiological Research
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2789780/
https://ncbi.nlm.nih.gov/pubmed/19578163
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1194/jlr.M900032-JLR200
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια